Patients who initiated insulin therapy with, or switched existing insulin therapy to, BIAsp 30 in routine care were eligible for this 26-week, non-interventional observational study.

• 起始胰岛素治疗，或转为胰岛素治疗的患者，符合条件者用门冬胰岛素30常规护理26周，非干预性观测研究。